nmda receptor antagonist cpp Search Results


potent nmda receptor antagonist (cpp)  (Swant)
90
Swant potent nmda receptor antagonist (cpp)
Effects of ICV injection of (A) saline or different doses of AP5 <t>(NMDA</t> receptor antagonist) (B) 1 mM (C) 5 mM, and (D) 25 mM/5 μL saline into the lateral ventricle on the maintenance and reinstatement of morphine in conditioned place preference paradigm. Animals received saline or AP5 during the extinction period (free morphine period). In the reinstatement day, animals received only priming dose of morphine (1 mg/kg; SC). Data are presented as mean±SEM for 6–7 rats. *P<0.05, ** P<0.01, and *** P<0.001 different from the pretest day. † P<0.05, †† P<0.01, and ††† P<0.001 different from the posttest day. +P<0.05, ++ P<0.01, and +++ P<0.001 different from the reinstatement day.
Potent Nmda Receptor Antagonist (Cpp), supplied by Swant, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/potent nmda receptor antagonist (cpp)/product/Swant
Average 90 stars, based on 1 article reviews
potent nmda receptor antagonist (cpp) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
nmda receptor antagonist (r,s)-3-(2-carbooxypiperazin-4-yl)propyl1-phosphonic (cpp)  (Stryker)
90
Stryker nmda receptor antagonist (r,s)-3-(2-carbooxypiperazin-4-yl)propyl1-phosphonic (cpp)
Effects of ICV injection of (A) saline or different doses of AP5 <t>(NMDA</t> receptor antagonist) (B) 1 mM (C) 5 mM, and (D) 25 mM/5 μL saline into the lateral ventricle on the maintenance and reinstatement of morphine in conditioned place preference paradigm. Animals received saline or AP5 during the extinction period (free morphine period). In the reinstatement day, animals received only priming dose of morphine (1 mg/kg; SC). Data are presented as mean±SEM for 6–7 rats. *P<0.05, ** P<0.01, and *** P<0.001 different from the pretest day. † P<0.05, †† P<0.01, and ††† P<0.001 different from the posttest day. +P<0.05, ++ P<0.01, and +++ P<0.001 different from the reinstatement day.
Nmda Receptor Antagonist (R,S) 3 (2 Carbooxypiperazin 4 Yl)Propyl1 Phosphonic (Cpp), supplied by Stryker, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nmda receptor antagonist (r,s)-3-(2-carbooxypiperazin-4-yl)propyl1-phosphonic (cpp)/product/Stryker
Average 90 stars, based on 1 article reviews
nmda receptor antagonist (r,s)-3-(2-carbooxypiperazin-4-yl)propyl1-phosphonic (cpp) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
competitive nmda-receptor antagonist cpp  (Stryker)
90
Stryker competitive nmda-receptor antagonist cpp
Effects of ICV injection of (A) saline or different doses of AP5 <t>(NMDA</t> receptor antagonist) (B) 1 mM (C) 5 mM, and (D) 25 mM/5 μL saline into the lateral ventricle on the maintenance and reinstatement of morphine in conditioned place preference paradigm. Animals received saline or AP5 during the extinction period (free morphine period). In the reinstatement day, animals received only priming dose of morphine (1 mg/kg; SC). Data are presented as mean±SEM for 6–7 rats. *P<0.05, ** P<0.01, and *** P<0.001 different from the pretest day. † P<0.05, †† P<0.01, and ††† P<0.001 different from the posttest day. +P<0.05, ++ P<0.01, and +++ P<0.001 different from the reinstatement day.
Competitive Nmda Receptor Antagonist Cpp, supplied by Stryker, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/competitive nmda-receptor antagonist cpp/product/Stryker
Average 90 stars, based on 1 article reviews
competitive nmda-receptor antagonist cpp - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
nmda receptor antagonist (±)-3-(2-carboxypiperazin-4-yl)-propyl1-phosphonic acid (cpp)  (Dawley Inc)
90
Dawley Inc nmda receptor antagonist (±)-3-(2-carboxypiperazin-4-yl)-propyl1-phosphonic acid (cpp)
Effects of ICV injection of (A) saline or different doses of AP5 <t>(NMDA</t> receptor antagonist) (B) 1 mM (C) 5 mM, and (D) 25 mM/5 μL saline into the lateral ventricle on the maintenance and reinstatement of morphine in conditioned place preference paradigm. Animals received saline or AP5 during the extinction period (free morphine period). In the reinstatement day, animals received only priming dose of morphine (1 mg/kg; SC). Data are presented as mean±SEM for 6–7 rats. *P<0.05, ** P<0.01, and *** P<0.001 different from the pretest day. † P<0.05, †† P<0.01, and ††† P<0.001 different from the posttest day. +P<0.05, ++ P<0.01, and +++ P<0.001 different from the reinstatement day.
Nmda Receptor Antagonist (±) 3 (2 Carboxypiperazin 4 Yl) Propyl1 Phosphonic Acid (Cpp), supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nmda receptor antagonist (±)-3-(2-carboxypiperazin-4-yl)-propyl1-phosphonic acid (cpp)/product/Dawley Inc
Average 90 stars, based on 1 article reviews
nmda receptor antagonist (±)-3-(2-carboxypiperazin-4-yl)-propyl1-phosphonic acid (cpp) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Effects of ICV injection of (A) saline or different doses of AP5 (NMDA receptor antagonist) (B) 1 mM (C) 5 mM, and (D) 25 mM/5 μL saline into the lateral ventricle on the maintenance and reinstatement of morphine in conditioned place preference paradigm. Animals received saline or AP5 during the extinction period (free morphine period). In the reinstatement day, animals received only priming dose of morphine (1 mg/kg; SC). Data are presented as mean±SEM for 6–7 rats. *P<0.05, ** P<0.01, and *** P<0.001 different from the pretest day. † P<0.05, †† P<0.01, and ††† P<0.001 different from the posttest day. +P<0.05, ++ P<0.01, and +++ P<0.001 different from the reinstatement day.

Journal: Basic and Clinical Neuroscience

Article Title: Reduction of the Morphine Maintenance by Blockade of the NMDA Receptors during Extinction Period in Conditioned Place Preference Paradigm of Rats

doi: 10.15412/J.BCN.03070407

Figure Lengend Snippet: Effects of ICV injection of (A) saline or different doses of AP5 (NMDA receptor antagonist) (B) 1 mM (C) 5 mM, and (D) 25 mM/5 μL saline into the lateral ventricle on the maintenance and reinstatement of morphine in conditioned place preference paradigm. Animals received saline or AP5 during the extinction period (free morphine period). In the reinstatement day, animals received only priming dose of morphine (1 mg/kg; SC). Data are presented as mean±SEM for 6–7 rats. *P<0.05, ** P<0.01, and *** P<0.001 different from the pretest day. † P<0.05, †† P<0.01, and ††† P<0.001 different from the posttest day. +P<0.05, ++ P<0.01, and +++ P<0.001 different from the reinstatement day.

Article Snippet: Additionally, systemic injection of the potent NMDA receptor antagonist (CPP) with low dose does not impair extinction memory in a self-administration paradigm ( Kelamangalath, Swant, Stramiello, & Wagner, 2007 ).

Techniques: Injection, Saline, Conditioned Place Preference

Effects of single dose injection of NMDA receptor antagonist (before extinction period) on the maintenance and reinstatement of morphine rewarding properties in conditioned place preference paradigm. Animals received a single injection of AP5(25 mM/5 μL saline; ICV) just after postconditioning CPP test. In this set of experiment, animals did not receive any drug (AP5) or saline/morphine during the extinction or reinstatement days. Data are presented as mean±SEM for 8 rats. **P<0.01 and *** P<0.001 different from the pretest day. †P<0.05 and ††† P<0.001 different from the posttest day. +P<0.05 and +++ P<0.001 different from the reinstatement day.

Journal: Basic and Clinical Neuroscience

Article Title: Reduction of the Morphine Maintenance by Blockade of the NMDA Receptors during Extinction Period in Conditioned Place Preference Paradigm of Rats

doi: 10.15412/J.BCN.03070407

Figure Lengend Snippet: Effects of single dose injection of NMDA receptor antagonist (before extinction period) on the maintenance and reinstatement of morphine rewarding properties in conditioned place preference paradigm. Animals received a single injection of AP5(25 mM/5 μL saline; ICV) just after postconditioning CPP test. In this set of experiment, animals did not receive any drug (AP5) or saline/morphine during the extinction or reinstatement days. Data are presented as mean±SEM for 8 rats. **P<0.01 and *** P<0.001 different from the pretest day. †P<0.05 and ††† P<0.001 different from the posttest day. +P<0.05 and +++ P<0.001 different from the reinstatement day.

Article Snippet: Additionally, systemic injection of the potent NMDA receptor antagonist (CPP) with low dose does not impair extinction memory in a self-administration paradigm ( Kelamangalath, Swant, Stramiello, & Wagner, 2007 ).

Techniques: Injection, Conditioned Place Preference, Saline

Effects of single dose injection of NMDA receptor antagonist on the reinstatement of morphine in conditioned place preference paradigm. Animals received a single injection of AP5(5 mM/5 μl saline; ICV) just prior to administration of priming dose of morphine (1 mg/kg; SC) in reinstatement day. Data are presented as mean±SEM for 8 rats. *P<0.05, ** P<0.01, and *** P<0.001 different from the pretest day. †P<0.05, †† P<0.01, and ††† P<0.001 different from the posttest day.

Journal: Basic and Clinical Neuroscience

Article Title: Reduction of the Morphine Maintenance by Blockade of the NMDA Receptors during Extinction Period in Conditioned Place Preference Paradigm of Rats

doi: 10.15412/J.BCN.03070407

Figure Lengend Snippet: Effects of single dose injection of NMDA receptor antagonist on the reinstatement of morphine in conditioned place preference paradigm. Animals received a single injection of AP5(5 mM/5 μl saline; ICV) just prior to administration of priming dose of morphine (1 mg/kg; SC) in reinstatement day. Data are presented as mean±SEM for 8 rats. *P<0.05, ** P<0.01, and *** P<0.001 different from the pretest day. †P<0.05, †† P<0.01, and ††† P<0.001 different from the posttest day.

Article Snippet: Additionally, systemic injection of the potent NMDA receptor antagonist (CPP) with low dose does not impair extinction memory in a self-administration paradigm ( Kelamangalath, Swant, Stramiello, & Wagner, 2007 ).

Techniques: Injection, Conditioned Place Preference, Saline